Drugs / buffered 2% hypertonic saline
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06822374 | Dec 2025 → May 2028 | idiopathic scoliosis | Joseph D. Tobias | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | buffered 2% hypertonic saline | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06822374 ↗ |